# A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care

> **NCT04834544** · PHASE2 · RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 75 (estimated)

## Conditions studied

- Epithelial Ovarian Carcinoma
- Fallopian Tube Carcinoma
- Primary Peritoneal Carcinoma

## Interventions

- **COMBINATION_PRODUCT:** DCVAC/OvCa
- **COMBINATION_PRODUCT:** Placebo

## Key facts

- **NCT ID:** NCT04834544
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-19
- **Primary completion:** 2024-10-20
- **Final completion:** 2027-04-20
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2021-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834544, "A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04834544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*